trehalose has been researched along with Diabetic Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, C; Liu, Y; Wu, S; Yan, X; Yang, Z; Yu, W; Zha, W; Zhao, Q | 1 |
| Ren, J; Wang, Q | 1 |
2 other study(ies) available for trehalose and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Trehalose Ameliorates Diabetic Cardiomyopathy: Role of the PK2/PKR Pathway.
Topics: Animals; Diabetic Cardiomyopathies; eIF-2 Kinase; Humans; Male; Mice; Signal Transduction; Transfection; Trehalose | 2021 |
mTOR-Independent autophagy inducer trehalose rescues against insulin resistance-induced myocardial contractile anomalies: Role of p38 MAPK and Foxo1.
Topics: Animals; Apoptosis; Autophagy; Calcium Signaling; Cardiotonic Agents; Diabetic Cardiomyopathies; Disease Models, Animal; Enzyme Activation; Forkhead Box Protein O1; Genetic Predisposition to Disease; Insulin Resistance; Mice, Knockout; Myocardial Contraction; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenotype; Phosphorylation; Proto-Oncogene Proteins c-akt; Time Factors; TOR Serine-Threonine Kinases; Trehalose; Ventricular Function, Left | 2016 |